Analysis Metabolite Name Measured Value Units Gender Glycemic status Neuropathy
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+30507Peak area normalizedmale Normoglycemic Neuropathy
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+49597Peak area normalizedfemale Pre-diabetic no neuropathy
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+55796Peak area normalizedmale Diabetic no neuropathy
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+56327Peak area normalizedmale Diabetic Neuropathy
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+59767Peak area normalizedfemale Pre-diabetic Neuropathy
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+62613Peak area normalizedfemale Pre-diabetic Neuropathy
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+67702Peak area normalizedmale Pre-diabetic no neuropathy
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+68522Peak area normalizedmale Diabetic Neuropathy
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+77028Peak area normalizedmale Pre-diabetic Neuropathy
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+79804Peak area normalizedfemale Pre-diabetic no neuropathy
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+80886Peak area normalizedfemale Pre-diabetic no neuropathy
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+86756Peak area normalizedmale Diabetic Neuropathy
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+99165Peak area normalizedfemale Diabetic no neuropathy
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+99206Peak area normalizedfemale Pre-diabetic Neuropathy
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+100705Peak area normalizedfemale Pre-diabetic no neuropathy
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+112051Peak area normalizedfemale Diabetic no neuropathy
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+112880Peak area normalizedfemale Diabetic Neuropathy
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+134316Peak area normalizedfemale Diabetic Neuropathy
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+141160Peak area normalizedmale Normoglycemic Neuropathy
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+149389Peak area normalizedmale Diabetic no neuropathy
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+172503Peak area normalizedmale Diabetic no neuropathy
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+210378Peak area normalizedfemale Pre-diabetic Neuropathy
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+247461Peak area normalizedmale Normoglycemic no neuropathy
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+338769Peak area normalizedmale Pre-diabetic no neuropathy
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+Peak area normalizedmale Normoglycemic no neuropathy
Reversed phase POSITIVE ION MODENICOTINAMIDE (M+H)+Peak area normalizedmale Pre-diabetic Neuropathy

Return to search page
  logo